1. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis. 1983; 148:795–801.
Article
2. Gray BM, Pass MA, Dillon HC Jr. Laboratory and field evaluation of selective media for isolation of group B streptococci. J Clin Microbiol. 1979; 9:466–70.
Article
3. Pasnick M, Mead PB, Philip AG. Selective maternal culturing to identify group B streptococcal infection. Am J Obstet Gynecol. 1980; 138:480–4.
Article
4. Gjerdingen DK. Premature labor, Part I: Risk assessment, etiologic factors, and diagnosis. J Am Board Fam Pract. 1992; 5:495–509.
5. Wilkinson HW. Group B streptococcal infection in humans. Ann Rev Microbiol. 1978; 32:41–57.
Article
6. Burman LG, Christensen P, Christensen K, Fryklund B, Helgesson AM, Svenningsen NW, et al. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. Lancet. 1992; 340:65–9.
Article
7. Campbell JR, Baker CJ, Edwards MS. Influence of serotype of group B streptococci on C3 degradation. Infect Immun. 1992; 60:4558–62.
Article
8. Uh Y, Jang IH, Hwang GY, Yoon KJ. Antimicrobial resistance and serotypes in the clinical isolates of group B streptococci. Korean J Clin Microbiol. 1999; 2:64–70.
9. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea. J Clin Microbiol. 2004; 42:3306–8.
Article
10. Uh Y, Kwon JY, Jang IH, Yoon KJ, Kim HG. Colonization rate of group B Streptococcus in pregnant women and neonates. Korean J Clin Pathol. 1994; 14:447–53.
11. Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC. Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis. 1997; 16:753–6.
Article
12. Uh Y, Jang IH, Yoon KJ, Kwon JY. Colonization rate and serotypes of group B streptococci in first trimester of pregnancy. Korean J Clin Pathol. 1998; 18:183–6.
13. Uh Y, Jang IH, Kwon JY, Kim NS, Kim MC, Park DW, et al. Studies on the usefulness of new Granada selective medium for the detection of group B streptococci in pregnant women. J Wonju Med Coll. 1996; 9:7–15.
14. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 8th ed., Approved standard M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.,. 2009.
15. CDC. Prevention of perinatal group B streptococcal Disease. MMWR. 2002; 51:1–22.
16. Centers for Disease Control and Prevention (CDC). Laboratory practices for prenatal group B streptococcal screening and reporting-Connecticut, Georgia, and Minnesota, 1997-1998. MMWR Morb Mortal Wkly Rep. 1999; 48:426–8.
17. Dillon HC Jr, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis. 1982; 145:794–9.
Article
18. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis. 1983; 148:802–9.
Article
19. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis. 1999; 179:1030–3.
Article
20. Uh Y, Kim HY, Jang IH, Hwang GY, Yoon KJ. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Med J. 2005; 46:480–3.